A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma

Area of Science:

• Genetics
• Oncology
• Bone Biology

Background:

• Osteosarcoma (OS) is a primary bone cancer predominantly affecting adolescents during periods of rapid growth.
• Genes regulating bone formation, growth, DNA repair, and ribosomal function are potential risk modifiers for OS.
• Investigating these genetic pathways may elucidate OS pathogenesis.

Purpose of the Study:

• To evaluate the association between genetic variations in growth/hormone, bone formation, DNA repair, and ribosomal pathways and osteosarcoma risk.
• To identify specific genes and single nucleotide polymorphisms (SNPs) associated with OS susceptibility.

Main Methods:

• A case-control study involving 96 OS cases and 1426 controls.
• Genotyping of 4836 tag single nucleotide polymorphisms (tag-SNPs) across 255 candidate genes.
• Logistic regression analysis to calculate odds ratios (OR) and 95% confidence intervals (CI).

Main Results:

• Twelve significant SNPs were identified in growth and DNA repair genes after Bonferroni correction.
• Four SNPs in the DNA repair gene FANCM (ORs 1.9-2.0) and two SNPs near the growth hormone gene GH1 (ORs 1.6, 0.5) were significantly associated with OS.
• Additional significant SNPs were found in or near MDM2, MPG, FGF2, FGFR3, GNRH2, and IGF1.

Conclusions:

• The study suggests an association between several SNPs in biologically relevant pathways and osteosarcoma risk.
• Findings indicate that genetic variations in growth and DNA repair pathways may influence OS development.
• Larger independent studies are necessary to validate these preliminary findings.